- List
- By Topic
- On Map
- Search Details
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
x
1 | NCT00782184 | Completed Has Results |
Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED) |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
250 | All | 18 Years to 79 Years (Adult, Senior) | NCT00782184 | 0653A-134 2008_576 |
November 2008 | September 2010 | September 2010 | October 31, 2008 | April 14, 2017 | October 31, 2011 |